Main Pages
Articles for $ENZN
Viskase Holdings, Inc. Completes Merger with Viskase Companies, Inc.Enzon Pharmaceuticals Completes Exchange Offer for Series C Preferred StockEnzon Pharmaceuticals Announces 1-for-100 Reverse Stock Split Effective March 24, 2026Enzon Pharmaceuticals Extends Exchange Offer for Series C Preferred Stock Until March 24, 2026Enzon Pharmaceuticals, Inc. Files Tenth Amendment to Section 382 Rights AgreementEnzon Pharmaceuticals Extends Exchange Offer for Series C Preferred Stock Until March 19, 2026